Gender |
|
|
Male |
53.8% |
7/13 |
Female |
46.2% |
6/13 |
Indifferent |
0% |
0/13 |
Unknown |
0% |
0/13 |
General |
|
|
Birth Length abnormalities |
0% |
0/0 |
Birth Weight abnormalities |
40.0% |
4/10 |
< P3 : Small for gestational age |
30.0% |
3/10 |
> P98 : Large for gestational age |
10.0% |
1/10 |
Birth Head circumference abnormalities |
0% |
0/1 |
Current Height abnormalities |
60.0% |
6/10 |
< P3 : Short stature |
60.0% |
6/10 |
Current Weight abnormalities |
50.0% |
3/6 |
> P98 : Increased body weight |
33.3% |
2/6 |
< P3 : Decreased body weight |
16.7% |
1/6 |
Current Head circumference abnormalities |
0% |
0/10 |
Neurology |
|
|
Neurological abnormalities |
69.2% |
9/13 |
Feeding difficulties |
30.8% |
4/13 |
Muscular hypotonia |
30.8% |
4/13 |
Seizures |
23.1% |
3/13 |
Dysphagia |
15.4% |
2/13 |
Delayed social development |
7.7% |
1/13 |
Hemiparesis |
7.7% |
1/13 |
Limb hypertonia |
7.7% |
1/13 |
Migraine |
7.7% |
1/13 |
Nystagmus |
7.7% |
1/13 |
Behavioral problems |
53.8% |
7/13 |
Sleep disturbance |
30.8% |
4/13 |
Attention deficit hyperactivity disorder |
23.1% |
3/13 |
Autism |
23.1% |
3/13 |
Abnormal aggressive, impulsive or violent behavior |
7.7% |
1/13 |
Hyperactivity |
7.7% |
1/13 |
Brain abnormality |
36.4% |
4/11 |
Aplasia/Hypoplasia of the corpus callosum |
9.1% |
1/11 |
Gliosis |
9.1% |
1/11 |
Retrocerebellar cyst |
9.1% |
1/11 |
Thick corpus callosum |
9.1% |
1/11 |
Facial abnormalities |
|
|
Abnormality of the ear |
61.5% |
8/13 |
Long ear |
61.5% |
8/13 |
Low-set, posteriorly rotated ears |
7.7% |
1/13 |
Abnormality of the eye |
84.6% |
11/13 |
Ptosis |
46.2% |
6/13 |
Downslanted palpebral fissures |
38.5% |
5/13 |
Upslanted palpebral fissure |
30.8% |
4/13 |
Strabismus |
15.4% |
2/13 |
Hypertelorism |
7.7% |
1/13 |
Large eyes |
7.7% |
1/13 |
Low-set, posteriorly rotated ears |
7.7% |
1/13 |
Small palpebral fissure |
7.7% |
1/13 |
Telecanthus |
7.7% |
1/13 |
Abnormality of the nose |
100.0% |
13/13 |
Prominent nasal tip |
100.0% |
13/13 |
Low hanging columella |
46.2% |
6/13 |
Prominent nasal bridge |
15.4% |
2/13 |
Depressed nasal bridge |
7.7% |
1/13 |
Short nasal bridge |
7.7% |
1/13 |
Abnormality of the mouth |
100.0% |
13/13 |
Wide mouth |
92.3% |
12/13 |
Thin upper lip vermilion |
84.6% |
11/13 |
Abnormality of the palate |
7.7% |
1/13 |
High palate |
7.7% |
1/13 |
Visual and hearing impairments |
|
|
Abnormal hearing |
15.4% |
2/13 |
Hearing impairment |
15.4% |
2/13 |
Enlarged vestibular aqueduct |
7.7% |
1/13 |
Abnormal vision |
15.4% |
2/13 |
Astigmatism |
7.7% |
1/13 |
Myopia |
7.7% |
1/13 |
Visual impairment |
7.7% |
1/13 |
Heart |
|
|
Abnormality of the heart |
15.4% |
2/13 |
Interrupted inferior vena cava with azygous continuation |
7.7% |
1/13 |
Ventricular septal defect |
7.7% |
1/13 |
Gastrointestinal |
|
|
Gastrointestinal abnormalities |
30.8% |
4/13 |
Episodic vomiting |
15.4% |
2/13 |
Duodenal atresia |
7.7% |
1/13 |
Feeding difficulties |
7.7% |
1/13 |
Urogenital |
|
|
Abnormality of the urogenital system |
7.7% |
1/13 |
Hypospadias |
7.7% |
1/13 |
Skeleton |
|
|
Skeletal abnormalities |
53.8% |
7/13 |
Joint hypermobility |
23.1% |
3/13 |
Pes planus |
15.4% |
2/13 |
Sandal gap |
15.4% |
2/13 |
Broad distal phalanx of the thumb |
7.7% |
1/13 |
Clinodactyly of the 5th toe |
7.7% |
1/13 |
Clinodactyly of the 5th finger |
7.7% |
1/13 |
Hip dysplasia |
7.7% |
1/13 |
Long fingers |
7.7% |
1/13 |
Scoliosis |
7.7% |
1/13 |
Short finger |
7.7% |
1/13 |
Small hand |
7.7% |
1/13 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
23.1% |
3/13 |
Abnormality of the teeth |
7.7% |
1/13 |
Hypodontia |
7.7% |
1/13 |
Hypopigmentation of hair |
7.7% |
1/13 |
Sandal gap |
7.7% |
1/13 |
Small finger |
7.7% |
1/13 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the endocrine system |
15.4% |
2/13 |
Congenital hypothyroidism |
7.7% |
1/13 |
Growth hormone deficiency |
7.7% |
1/13 |
Vitamin D deficiency |
7.7% |
1/13 |
Abnormality of the immune system |
7.7% |
1/13 |
Recurrent urinary tract infections |
7.7% |
1/13 |
Neoplasia |
|
|
Neoplasia |
15.4% |
2/13 |
Acute myeloid leukemia |
7.7% |
1/13 |
Hodgkin lymphoma |
7.7% |
1/13 |